NEW YORK (Reuters Health) – A cause of visible hematuria can be determined in almost half of cases, according to a report from Aberdeen Royal Infirmary in Scotland,…
NEW YORK (Reuters Health) – The 2009 influenza A(H1N1) pandemic caused severe illness and mortality in cancer patients with solid tumors, investigators report in Cancer online February 22.…
NEW YORK (Reuters Health) – Early ischemic events are reduced in patients undergoing percutaneous coronary intervention for acute coronary syndrome when they’re treated with cangrelor rather than clopidogrel…
NEW YORK (Reuters Health) – Results of a meta-analysis indicate that patients with chronic kidney disease (CKD) derive little net benefit from antiplatelet therapy in terms of cardiovascular…
NEW YORK (Reuters Health) – Golimumab, a new anti-TNF monoclonal antibody, administered subcutaneously every 4 weeks, shows sustained efficacy in reducing signs and symptoms of active psoriatic arthritis…
NEW YORK (Reuters Health) – In high-risk hypertensive patients with or without prior coronary artery disease, adding the angiotensin receptor II blocker valsartan to conventional non-ARB treatment reduces…
NEW YORK (Reuters Health) – The lipid-modifying effects of rosuvastatin (Crestor: AstraZeneca) are stronger than atorvastatin (Lipitor; Pfizer) in patients with an acute coronary syndrome (ACS), according to…
NEW YORK (Reuters Health) – A transdermal sumatriptan formulation, NP101, in development for acute treatment of migraine, remains effective during a year of successive uses, according to a…
NEW YORK (Reuters Health) – The benefit of renin-angiotensin system inhibition in systolic heart failure (HF) extends to older patients with chronic kidney disease (CKD), a new study…
NEW YORK (Reuters Health) – When antiepileptic drug therapy fails to control disabling temporal lobe epilepsy adequately, patients have a much better chance of becoming seizure free with…